Sanara MedTech insider tax-withholding share disposition

Sanara MedTech Inc. Controller Ashley M. Mackey reported a tax-related share disposition.

Rhea-AI Filing Summary

Sanara MedTech Inc. Controller Ashley M. Mackey reported a tax-related share disposition. The company withheld 149 shares of common stock at $19.90 per share to cover tax obligations tied to the vesting of 502 restricted shares. After this withholding, Mackey directly owns 2,263 common shares.

Insider Trade Summary

Exercise Price or Tax Liability: 149 shares

Exercise Price or Tax Liability 1 txn

Insider Mackey Ashley M

Role Controller

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	149	$19.90	$3K

Holdings After Transaction: Common Stock — 2,263 shares (Direct)

Footnotes (1)

1. F1. Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 502 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Sanara MedTech (SMTI) report for Ashley M. Mackey?

Sanara MedTech reported that Controller Ashley M. Mackey had 149 common shares withheld to satisfy tax obligations from vesting restricted stock. This Form 4 reflects a tax-withholding disposition, not an open-market trade or new share issuance, and is part of routine equity compensation.

How many Sanara MedTech (SMTI) shares were involved in the tax withholding?

The transaction involved 149 shares of Sanara MedTech common stock withheld by the company. These shares covered tax obligations arising from the annual vesting of 502 previously granted restricted shares, using a per-share value of $19.90 on the vesting date reported on the Nasdaq Capital Market.

Was the Sanara MedTech (SMTI) Form 4 a sale of shares on the market?

No, the Form 4 states that no shares were issued or sold in this transaction. The 149 shares were withheld by Sanara MedTech to satisfy tax liabilities from restricted stock vesting, rather than being sold in open-market or privately negotiated transactions.

What price was used for the Sanara MedTech (SMTI) tax-withheld shares?

The withheld 149 shares were valued at $19.90 per share. The filing explains this per-share value reflects the Nasdaq Capital Market price on the date the 502 restricted shares vested, and is used solely for determining the tax-withholding amount reported.

How many Sanara MedTech (SMTI) shares does Ashley M. Mackey own after the transaction?

After the tax-withholding disposition, Ashley M. Mackey directly owns 2,263 shares of Sanara MedTech common stock. This total reflects the reduction from the 149 shares withheld to cover tax obligations related to the annual vesting of previously granted restricted stock awards.

What triggered the tax-withholding share disposition at Sanara MedTech (SMTI)?

The disposition was triggered by the annual vesting of 502 restricted shares previously granted to Ashley M. Mackey. To cover resulting tax obligations, Sanara MedTech withheld 149 of those shares, recording the event as a tax-withholding disposition on Form 4 rather than a market sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/27/2026 - 04:18 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mackey Ashley M

(Last) (First) (Middle)

1200 SUMMIT AVE

SUITE 414

(Street)

FORT WORTH TX 76102

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Sanara MedTech Inc. [ SMTI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Controller

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/25/2026		F		149(1)	D	$19.9(1)	2,263	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 502 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

	/s/ Ashley M. Mackey	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.